Farther Finance Advisors’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-305
Closed -$5.49K 4711
2025
Q1
$5.49K Hold
305
﹤0.01% 3013
2024
Q4
$5.33K Sell
305
-58
-16% -$784 ﹤0.01% 2639
2024
Q3
$4.18K Buy
363
+30
+9% +$344 ﹤0.01% 2717
2024
Q2
$3.8K Hold
333
﹤0.01% 2519
2024
Q1
$4.74K Hold
333
﹤0.01% 2093
2023
Q4
$4.57K Buy
333
+183
+122% +$1.93K ﹤0.01% 2011
2023
Q3
$1.22K Hold
150
﹤0.01% 2020
2023
Q2
$1.14K Hold
150
﹤0.01% 1931
2023
Q1
$1.2K Hold
150
﹤0.01% 1803
2022
Q4
$1.7K Buy
+150
New +$1.64K ﹤0.01% 1507

Farther Finance Advisors's PTVE Position: Q2 2025 in Review

Farther Finance Advisors sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2025, closing a stake of 305 shares — an estimated $5.49K sold.

Farther Finance Advisors first reported a position in PTVE in Q4 2022 and held it in 10 quarters. The position peaked at $5.49K in Q1 2025. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.

  • Farther Finance Advisors reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2025 after selling out during the quarter.
  • Farther Finance Advisors sold 305 Pactiv Evergreen Inc. Common stock shares in Q2 2025, an estimated $5.49K.
  • Farther Finance Advisors first reported a position in Pactiv Evergreen Inc. Common stock in Q4 2022 and held it in 10 quarters.
  • Farther Finance Advisors's Pactiv Evergreen Inc. Common stock position peaked at $5.49K in Q1 2025.
  • 0 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2025.

Based on Farther Finance Advisors's 13F filing for Q2 2025, filed 11 Jul 2025.